Enterprise Value
311.8M
Cash
48.19M
Avg Qtr Burn
N/A
Short % of Float
0.47%
Insider Ownership
7.32%
Institutional Own.
49.21%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Inhaled AAT Details Severe alpha-1 antitrypsin deficiency | Phase 3 Data readout | |
Failed Discontinued |